Back to Screener

Healthcare

Fate Therapeutics, Inc.(FATE)

Live Price

Offline

$1.87

-9.22% today

1Y Change

+90.00%

Window

Jun 26, 2025 โ†’ Jun 18, 2026

Market Cap
$270.00M
Revenue Growth
-51.2%
EPS Growth
+29.9%
Dividend Yield
0.0%

Coverage: 246 bars ยท Jun 26, 2025 โ†’ Jun 18, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Fate Therapeutics, Inc. (FATE) is a Healthcare stock with a market cap of $270.00M and listed on NASDAQ. The stock last traded around $1.87 and up 90.0% across the available one-year price window (Jun 26, 2025 โ†’ Jun 18, 2026). Baseline metrics include revenue growth of -51.2%, EPS growth of +29.9%, a dividend yield of 0.0%. What stands out right now is revenue -51.2%, EPS +29.9%, free cash flow +9.4% with operating margin -2222.4% and ROIC -51.4%. Valuation already assumes a fairly strong business story at price/sales 40.1. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines FATE price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

FATE vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

FATE

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

FATE Max Drawdown

-41.82%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for FATE and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 12, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 12, 26
โ€”
Est -0.30
โ€”
โ€”
Est 1491.1B
โ€”
May 12
โ€”
Feb 26, 26
โ€”
-0.27
Est -0.27
0.0%
1369.0B
Est 1336.6B
+2.4%
Feb 26
โ€”
Nov 13, 25
โœ“
-0.27
Est -0.29
+6.9%
1741.0B
Est 1198.1B
+45.3%
Nov 13
โ€”
Aug 12, 25
โœ“
-0.29
Est -0.35
+17.1%
1907.0B
Est 1148.9B
+66.0%
Aug 12
โ€”
May 13, 25
โœ“
-0.32
Est -0.39
+17.9%
1629.0B
Est 1184.4B
+37.5%
May 13
โ€”
Mar 5, 25
โœ“
-0.31
Est -0.44
+29.6%
1860.0B
Est 1568.7B
+18.6%
Mar 5
โ€”
Nov 12, 24
โœ“
-0.40
Est -0.42
+4.8%
3074.0B
Est 1320.0B
+132.9%
Nov 12
โ€”
Aug 13, 24
โœ“
-0.33
Est -0.47
+29.8%
6772.0B
Est 1410.0B
+380.3%
Aug 13
โ€”
May 9, 24
โ€”
-0.47
Est -0.47
0.0%
1925.0B
Est 1110.0B
+73.4%
May 9
โ€”
Feb 26, 24
โœ“
-0.45
Est -0.57
+21.1%
1676.0B
Est 1590.0B
+5.4%
Feb 26
โ€”
Nov 8, 23
โœ“
-0.46
Est -0.59
+22.0%
1944.0B
Est 1640.0B
+18.5%
Nov 8
โ€”
Aug 8, 23
โœ“
-0.54
Est -0.58
+6.9%
933.0B
Est 5530.0B
-83.1%
Aug 8
โ€”
May 3, 23
โœ“
-0.19
Est -0.55
+65.5%
58980.0B
Est 35500.0B
+66.1%
May 3
โ€”
Feb 28, 23
โœ“
-0.58
Est -0.86
+32.6%
44356.0B
Est 17880.6B
+148.1%
Feb 28
โ€”
Nov 3, 22
โœ“
-0.86
Est -0.93
+7.5%
14981.0B
Est 15280.5B
-2.0%
Nov 3
โ€”
Aug 3, 22
โœ“
-0.79
Est -0.86
+8.1%
18549.0B
Est 12537.2B
+48.0%
Aug 3
โ€”
May 4, 22
โœ“
-0.68
Est -0.78
+12.8%
18414.0B
Est 9011.3B
+104.3%
May 4
โ€”
Feb 28, 22
โœ—
-0.72
Est -0.68
-5.9%
17067.0B
Est 11309.1B
+50.9%
Feb 28
โ€”
Nov 4, 21
โœ“
-0.57
Est -0.58
+1.7%
14225.0B
Est 7890.0B
+80.3%
Nov 4
โ€”
Aug 4, 21
โœ—
-0.58
Est -0.52
-11.5%
13412.0B
Est 13412.0B
0.0%
Aug 4
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener